Millennium Management
BIOC

Millennium Management’s Biocept, Inc. BIOC Stock Holding History

Millennium Management’s Portfolio BIOC Stock Details BIOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,234
Closed -$34K – 7326
2022
Q3 		$34K Sell
1,234
-2,203
-64% -$65.2K ﹤0.01% 6305
2022
Q2 		$97K Buy
+3,437
New +$157K ﹤0.01% 5952
2017
Q4 		– Sell
-3
Closed -$28K – 4175
2017
Q3 		$28K Buy
+3
New +$35.5K ﹤0.01% 3436

Other funds holding BIOC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TMWM
Taylor & Morgan Wealth Management Flint, Michigan $203M AUM 24.74% 1-Year Est. Return

Millennium Management's BIOC Position: Q4 2022 in Review

Millennium Management sold out of Biocept, Inc. (BIOC) in Q4 2022, closing a stake of 1,234 shares — an estimated $34K sold.

Millennium Management first reported a position in BIOC in Q3 2017 and held it in 3 quarters. The position peaked at $97K in Q2 2022. 25 funds tracked by Wall St. Rank hold BIOC as of Q4 2022.

  • Millennium Management reported no remaining Biocept, Inc. position as of Q4 2022 after selling out during the quarter.
  • Millennium Management sold 1,234 Biocept, Inc. shares in Q4 2022, an estimated $34K.
  • Millennium Management first reported a position in Biocept, Inc. in Q3 2017 and held it in 3 quarters.
  • Millennium Management's Biocept, Inc. position peaked at $97K in Q2 2022.
  • 25 funds tracked by Wall St. Rank held Biocept, Inc. as of Q4 2022.

Based on Millennium Management's 13F filing for Q4 2022, filed 14 Feb 2023.